Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Clin Oral Implants Res ; 25(2): e133-9, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23210635

RESUMO

OBJECTIVES: Phosphoserine-based functionalization has been proposed as a tool to improve integration of endosseous implants by promoting osteoblast adhesion and differentiation in vitro. The present work investigates whether phosphoserine-tethered poly(epsilon-lysine) dendrons, when applied as a film to titanium surfaces, enhance the differentiation of osteoblastic cells and the activation of Wnt/ß-catenin signaling. MATERIALS AND METHODS: These films were tested in a murine model of calvaria-derived MC3T3 osteoblastic cells, primary bone marrow cells and mesenchymal, undifferentiated C2C12 cells. Gene expression was assayed by Real Time PCR, and activation of Wnt signaling pathway was measured with a reporter assay. RESULTS: Dendrons increased expression of alkaline phosphatase and osteocalcin, two osteoblastic markers, in both murine osteoblastic MC3T3 cells and primary bone marrow cells. The expression of osteoprotegerin, a protein opposing osteoclastogenesis was also significantly higher in cells growing on dendron-coated substrates both at 3 and 6 days of culture. Similarly, the mRNA levels of Wisp-2 and of ß-catenin, two Wnt target genes, were also markedly increased in this group at day 6. The activation of this signaling pathway in cells growing on the dendron-coated surfaces was confirmed by use of a TCF/ß-catenin reporter system in the C2C12 cell line. CONCLUSIONS: The findings of the present study show that phosphoserine-tethered poly(epsilon-lysine) dendron films act as stimuli for the activation of specific signal cascades and promote the differentiation of adhering progenitor cells into an osteoblastic phenotype.


Assuntos
Biomimética , Materiais Revestidos Biocompatíveis , Dendrímeros/farmacologia , Lisina/farmacologia , Osteoblastos/fisiologia , Fosfosserina/farmacologia , Titânio/farmacologia , Via de Sinalização Wnt/fisiologia , Condicionamento Ácido do Dente , Fosfatase Alcalina/metabolismo , Animais , Biomarcadores/metabolismo , Adesão Celular , Diferenciação Celular , Células Cultivadas , Cromatografia Líquida de Alta Pressão , Espectrometria de Massas , Camundongos , Microscopia Eletrônica de Varredura , Osteocalcina/metabolismo , Reação em Cadeia da Polimerase em Tempo Real , Transdução de Sinais/fisiologia , Propriedades de Superfície
2.
J Tissue Eng Regen Med ; 12(2): e669-e678, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-27718530

RESUMO

Damage of non-vascularised tissues such as cartilage and cornea can result in healing processes accompanied by a non-physiological angiogenesis. Peptidic aptamers have recently been reported to block the vascular endothelial growth factor (VEGF). However, the therapeutic applications of these aptamers are limited due to their short half-life in vivo. In this work, an enhanced stability and bioavailability of a known VEGF blocker aptamer sequence (WHLPFKC) was pursued through its tethering of molecular scaffolds based on hyperbranched peptides, the poly(ɛ-lysine) dendrons, bearing three branching generations. The proposed design allowed simultaneous and orderly-spaced exposure of 16 aptamers per dendrimer to the surrounding biological microenvironent, as well as a relatively hydrophobic core based on di-phenylalanine aiming to promote an hydrophobic interaction with the hydrophobic moieties of ionically crosslinked methacrylated gellan gum (iGG-MA) hydrogels. The VEGF blocker dendrons were entrapped in iGG-MA hydrogels, and their capacity to prevent endothelial cell sprouting was assessed qualitatively and quantitatively using 3D in vitro models and the in vivo chick chorioallantoic membrane assay. The data demonstrate that at nanoscale concentrations, the dendronised structures were able to enhance control of the biological actvity of WHLPFKC at the material/tissue interface and hence the anti-angiogenic capacity of iGG-MA hydrogels not only preventing blood vessel invasion, but also inducing their regression at the tissue/iGG-MA interface. The in ovo study confirmed that iGG-MA functionalised with the dendron VEGF blockers do inhibit angiogenesis by controlling both size and ramifications of blood vessels in the proximity of the implanted gel surface. Copyright © 2016 John Wiley & Sons, Ltd.


Assuntos
Antracenos/farmacologia , Hidrogéis/farmacologia , Neovascularização Fisiológica/efeitos dos fármacos , Polissacarídeos Bacterianos/farmacologia , Engenharia Tecidual/métodos , Fator A de Crescimento do Endotélio Vascular/antagonistas & inibidores , Animais , Galinhas , Membrana Corioalantoide/efeitos dos fármacos , Membrana Corioalantoide/metabolismo , Reagentes de Ligações Cruzadas/farmacologia , Células Endoteliais da Veia Umbilical Humana/efeitos dos fármacos , Células Endoteliais da Veia Umbilical Humana/metabolismo , Humanos , Metacrilatos/farmacologia , Microvasos/diagnóstico por imagem , Microvasos/efeitos dos fármacos , Fator A de Crescimento do Endotélio Vascular/metabolismo
3.
Eur J Pharm Sci ; 106: 362-380, 2017 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-28629803

RESUMO

Inhalation of nanoparticles for pulmonary drug delivery offers the potential to harness nanomedicine formulations of emerging therapeutics, such as curcumin, for treatment of lung cancer. Biocompatible nanoparticles composed of poly(2-methacryloyloxyethyl phosphorylcholine)-b-poly(2-(diisopropylamino)ethyl methacrylate) (MPC-DPA) have been shown to be suitable nanocarriers for drugs, whilst N-trimethyl chitosan chloride (TMC) coating of nanoparticles has been reported to further enhance their cellular delivery efficacy; the combination of the two has not been previously investigated. Development of effective systems requires the predictable, controllable, and reproducible ability to prepare nanosystems possessing particle sizes, and drug loading capacities, appropriate for successful airway travel, lung tissue penetration, and tumor suppression. Although a number of MPC-DPA based nanosystems have been described, a complete understanding of parameters controlling nanoparticle formation, size, and morphology has not been reported; in particular the effects of differing solvents phases remains unclear. In this current study a matrix of 31 solvent combinations were examined to provide novel data pertaining to the formation of MPC-DPA nanoparticles, and in doing so afforded the selection of systems with particle sizes appropriate for pulmonary delivery applications to be loaded with curcumin, and coated with TMC. This paper presents the first report of novel data detailing the successful preparation, characterisation, and optimisation of MPC-DPA nanoparticles of circa 150-180nm diameter, with low polydispersity, and a curcumin loading range of circa 2.5-115µM, tunable by preparation parameters, with and without TMC coating, and thus considered suitable candidates for inhalation drug delivery applications.


Assuntos
Portadores de Fármacos/química , Nanopartículas/química , Fosforilcolina/análogos & derivados , Ácidos Polimetacrílicos/química , Administração por Inalação , Quitosana/química , Curcumina/química , Microscopia Eletrônica de Transmissão e Varredura , Nanopartículas/ultraestrutura , Fosforilcolina/química , Solubilidade , Solventes/química
4.
Tissue Eng Part A ; 18(17-18): 1932-9, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22616570

RESUMO

The successful regeneration of large defects in traumatized and diseased tissues depends on the availability of biodegradable and bioactive biomaterials able to guide the tissue during its repair by offering both a physical support and a control of its biological mechanisms. Recently, a novel class of natural, biodegradable biomaterials has been obtained by the thermosetting of defatted soy curd. These biomaterials have been shown to regulate the activity of both tissue and inflammatory cells. Here, soybean-based hydrogels with different physicochemical properties and bioactivity have been obtained with a relatively simple and highly reproducible processing method. The content of the different soy components (e.g., the isoflavones) was tuned varying the solvent system during the extraction procedure, while variations in the material crosslinking provided either loose hydrogels or a bioglue. The biomaterials obtained can be used as either bioadhesives or injectable formulations in regenerative medicine as they were shown to stimulate the synthesis of collagen by fibroblasts and the formation of mineralized bone noduli by osteoblasts.


Assuntos
Materiais Biocompatíveis/síntese química , Materiais Biocompatíveis/farmacologia , Diferenciação Celular/efeitos dos fármacos , Glycine max/química , Hidrogéis/síntese química , Hidrogéis/farmacologia , Varredura Diferencial de Calorimetria , Linhagem Celular , Cromatografia Líquida de Alta Pressão , Farinha , Humanos , Isoflavonas/análise , L-Lactato Desidrogenase/metabolismo , Teste de Materiais , Reologia/efeitos dos fármacos , Espectroscopia de Infravermelho com Transformada de Fourier
5.
Macromol Biosci ; 11(12): 1761-5, 2011 Dec 08.
Artigo em Inglês | MEDLINE | ID: mdl-22110001

RESUMO

To overcome the lack of in vivo stability of certain peptides used in cancer treatment and to increase their retention time in the extracellular matrix of the target tissue, the anti-angiogenic WHLPFKC sequence is synthesised at the uppermost branching generation of a poly(ε-lysine) dendron. The root of these dendrons is designed to interact preferentially with macromolecules of the extracellular matrix, whilst the uppermost branching generation of the dendron increased the exposed density of the bioactive peptide. Bioactivity testing of the blockers is performed on HUVECs. The results show that the dendron tethered with VEGF blockers was still able to inhibit proliferation and angiogenesis. Their relatively larger structure did not prevent the interaction with VEGF.


Assuntos
Inibidores da Angiogênese/farmacologia , Antracenos/farmacologia , Endotélio Vascular/efeitos dos fármacos , Neovascularização Patológica/prevenção & controle , Peptídeos/farmacologia , Fator A de Crescimento do Endotélio Vascular/antagonistas & inibidores , Inibidores da Angiogênese/síntese química , Antracenos/síntese química , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Colágeno/química , Combinação de Medicamentos , Endotélio Vascular/patologia , Matriz Extracelular/metabolismo , Células Endoteliais da Veia Umbilical Humana , Humanos , Laminina/química , Peptídeos/síntese química , Polilisina/química , Proteoglicanas/química , Técnicas de Síntese em Fase Sólida , Fator A de Crescimento do Endotélio Vascular/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA